Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA)

Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA)

US Patent 11730792 · Granted Aug 22, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating primary sclerosing cholangitis2025
Predicting outcome of treatment with an anti-α4β7 integrin antibody2023
Coversin variants lacking C5 binding2022
Method of inhibiting C5 cleavage2017
Complement inhibitors2015
Detection of amplicon contamination during PCR exhibiting two different annealin2011
Complement inhibitors2011